Sunnyvale, CA, United States of America

Felix Sana

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Palo Alto LLC. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Felix Sana. Retrieved from https://idiyas.com/inventor/felix-sana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Felix Sana: Innovator in Pharmaceutical Composition

Introduction

Felix Sana is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent.

Latest Patents

Felix holds a patent for a pharmaceutical composition and process. The invention relates to a method of forming granules of a specific compound, which involves mixing the compound with a granulating liquid and a polyethylene glycol/polypropylene glycol block copolymer as a binder and solubility enhancer. This process results in the formation of wet granules that are subsequently dried to remove the granulating liquid.

Career Highlights

Throughout his career, Felix has worked with prominent companies in the pharmaceutical industry, including Roche Palo Alto LLC and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Felix has collaborated with talented professionals in his field, including Dimitrios Stefanidis and Shridhar Hegde. These collaborations have likely enriched his work and led to further advancements in pharmaceutical compositions.

Conclusion

Felix Sana is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. His innovative methods and collaborations highlight his commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…